Bath application normalized to the first bath application of NMDA (100 M)
The use of alternating high-fat diets and glucagon-like peptide-1 (GLP-1) agonists has been shown to ameliorate the metabolic consequences of hyperinsulinemia, hyperlipidemia, and hepatic steatosis in mice [225]
Theyre fascinating drugs for which scientists have already found many good uses, Standaert says, but that doesnt mean they cure everything. At this point, he says, I think we need to back up a little bit and ask ourselves, How do these GLP-1s work anyway? Sperling echoes the thought
Yes, when managed by a medical professional
As such, optimal health outcomes with GLP-1RA require a multifaceted approach beyond pharmacological interventions, encompassing lifestyle modifications like diet and exercise
S2CID 13300428